Thomas A Szlosek, a director at $RXO, bought 20,308 shares of the company on 11-07-2025 for an estimated $251,209. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 125.4%. Following this trade, they now own 36,508 shares of this class of $RXO stock.
$RXO Insider Trading Activity
$RXO insiders have traded $RXO stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- THOMAS A SZLOSEK has made 2 purchases buying 27,808 shares for an estimated $376,084 and 0 sales.
- ANDREW M. WILKERSON (Chief Executive Officer) has made 2 purchases buying 11,625 shares for an estimated $149,422 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXO Hedge Fund Activity
We have seen 148 institutional investors add shares of $RXO stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,730,665 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,926,053
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,315,519 shares (-66.9%) from their portfolio in Q2 2025, for an estimated $20,679,958
- FRANKLIN RESOURCES INC removed 1,155,234 shares (-48.7%) from their portfolio in Q2 2025, for an estimated $18,160,278
- ORBIS ALLAN GRAY LTD added 1,142,710 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $17,963,401
- FRED ALGER MANAGEMENT, LLC removed 1,100,145 shares (-52.3%) from their portfolio in Q2 2025, for an estimated $17,294,279
- MACQUARIE GROUP LTD removed 974,894 shares (-80.5%) from their portfolio in Q2 2025, for an estimated $15,325,333
- VICTORY CAPITAL MANAGEMENT INC removed 955,302 shares (-97.2%) from their portfolio in Q2 2025, for an estimated $15,017,347
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 11/11/2025
- Susquehanna issued a "Negative" rating on 11/07/2025
- Barclays issued a "Overweight" rating on 11/07/2025
- Truist Securities issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.
$RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 9 analysts offer price targets for $RXO in the last 6 months, with a median target of $16.0.
Here are some recent targets:
- Ravi Shanker from Morgan Stanley set a target price of $19.0 on 11/11/2025
- Bascome Majors from Susquehanna set a target price of $10.0 on 11/07/2025
- Brandon Oglenski from Barclays set a target price of $15.0 on 11/07/2025
- Thomas Wadewitz from UBS set a target price of $15.0 on 11/07/2025
- Lucas Servera from Truist Securities set a target price of $20.0 on 11/07/2025
- J. Bruce Chan from Stifel set a target price of $17.0 on 10/10/2025
- Jordan Alliger from Goldman Sachs set a target price of $15.0 on 10/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
